177 related articles for article (PubMed ID: 14625300)
1. Desensitization masks nanomolar potency of ATP for the P2X1 receptor.
Rettinger J; Schmalzing G
J Biol Chem; 2004 Feb; 279(8):6426-33. PubMed ID: 14625300
[TBL] [Abstract][Full Text] [Related]
2. Activation and desensitization of the recombinant P2X1 receptor at nanomolar ATP concentrations.
Rettinger J; Schmalzing G
J Gen Physiol; 2003 May; 121(5):451-61. PubMed ID: 12719485
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the binding characteristics of recombinant P2X1 and P2X2 purinoceptors.
Michel AD; Lundström K; Buell GN; Surprenant A; Valera S; Humphrey PP
Br J Pharmacol; 1996 Aug; 118(7):1806-12. PubMed ID: 8842447
[TBL] [Abstract][Full Text] [Related]
4. The ATP-gated P2X1 ion channel acts as a positive regulator of platelet responses to collagen.
Oury C; Toth-Zsamboki E; Thys C; Tytgat J; Vermylen J; Hoylaerts MF
Thromb Haemost; 2001 Nov; 86(5):1264-71. PubMed ID: 11816716
[TBL] [Abstract][Full Text] [Related]
5. 2', 3'-O-(2,4,6,trinitrophenyl)-ATP and A-317491 are competitive antagonists at a slowly desensitizing chimeric human P2X3 receptor.
Neelands TR; Burgard EC; Uchic ME; McDonald HA; Niforatos W; Faltynek CR; Lynch KJ; Jarvis MF
Br J Pharmacol; 2003 Sep; 140(1):202-10. PubMed ID: 12967950
[TBL] [Abstract][Full Text] [Related]
6. Dissecting individual current components of co-expressed human P2X1 and P2X7 receptors.
Seyffert C; Schmalzing G; Markwardt F
Curr Top Med Chem; 2004; 4(16):1719-30. PubMed ID: 15579104
[TBL] [Abstract][Full Text] [Related]
7. The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range.
Horner S; Menke K; Hildebrandt C; Kassack MU; Nickel P; Ullmann H; Mahaut-Smith MP; Lambrecht G
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):1-13. PubMed ID: 16158305
[TBL] [Abstract][Full Text] [Related]
8. P2X receptor chimeras highlight roles of the amino terminus to partial agonist efficacy, the carboxyl terminus to recovery from desensitization, and independent regulation of channel transitions.
Allsopp RC; Farmer LK; Fryatt AG; Evans RJ
J Biol Chem; 2013 Jul; 288(29):21412-21421. PubMed ID: 23740251
[TBL] [Abstract][Full Text] [Related]
9. Functional and biochemical evidence for heteromeric ATP-gated channels composed of P2X1 and P2X5 subunits.
Lê KT; Boué-Grabot E; Archambault V; Séguéla P
J Biol Chem; 1999 May; 274(22):15415-9. PubMed ID: 10336430
[TBL] [Abstract][Full Text] [Related]
10. P2X purinoceptors in cultured myenteric neurons of guinea-pig small intestine.
Zhou X; Galligan JJ
J Physiol; 1996 Nov; 496 ( Pt 3)(Pt 3):719-29. PubMed ID: 8930839
[TBL] [Abstract][Full Text] [Related]
11. Selective potentiation of homomeric P2X2 ionotropic ATP receptors by a fast non-genomic action of progesterone.
De Roo M; Boué-Grabot E; Schlichter R
Neuropharmacology; 2010 Mar; 58(3):569-77. PubMed ID: 20004677
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cultured dorsal root ganglion neuron P2X receptors.
Grubb BD; Evans RJ
Eur J Neurosci; 1999 Jan; 11(1):149-54. PubMed ID: 9987019
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of selective antagonism of the P2X1 receptor for ATP by NF449 and suramin: contribution of basic amino acids in the cysteine-rich loop.
El-Ajouz S; Ray D; Allsopp RC; Evans RJ
Br J Pharmacol; 2012 Jan; 165(2):390-400. PubMed ID: 21671897
[TBL] [Abstract][Full Text] [Related]
14. Purinoreceptor-mediated current in myocytes from renal resistance arteries.
Harhun MI; Povstyan OV; Gordienko DV
Br J Pharmacol; 2010 Jun; 160(4):987-97. PubMed ID: 20590593
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of P2X(3) and P2X(2) receptor subunits in varying amounts generates heterogeneous populations of P2X receptors that evoke a spectrum of agonist responses comparable to that seen in sensory neurons.
Liu M; King BF; Dunn PM; Rong W; Townsend-Nicholson A; Burnstock G
J Pharmacol Exp Ther; 2001 Mar; 296(3):1043-50. PubMed ID: 11181939
[TBL] [Abstract][Full Text] [Related]
16. Functional ligand-gated purinergic receptors (P2X) in rat vestibular ganglion neurons.
Ito K; Chihara Y; Iwasaki S; Komuta Y; Sugasawa M; Sahara Y
Hear Res; 2010 Aug; 267(1-2):89-95. PubMed ID: 20430087
[TBL] [Abstract][Full Text] [Related]
17. Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels.
Lewis CJ; Evans RJ
Br J Pharmacol; 2000 Dec; 131(8):1659-66. PubMed ID: 11139444
[TBL] [Abstract][Full Text] [Related]
18. The intracellular amino terminus plays a dominant role in desensitization of ATP-gated P2X receptor ion channels.
Allsopp RC; Evans RJ
J Biol Chem; 2011 Dec; 286(52):44691-701. PubMed ID: 22027824
[TBL] [Abstract][Full Text] [Related]
19. Co-expression of P2X1 and P2X5 receptor subunits reveals a novel ATP-gated ion channel.
Torres GE; Haines WR; Egan TM; Voigt MM
Mol Pharmacol; 1998 Dec; 54(6):989-93. PubMed ID: 9855626
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of cloned P2X receptors.
North RA; Surprenant A
Annu Rev Pharmacol Toxicol; 2000; 40():563-80. PubMed ID: 10836147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
